(Q36150445)

12 August 2017

1 reference

title

Advances in allergen-specific immunotherapy. (English)

1 reference

12 August 2017

1 reference

2

Alison Taylor

1 reference

12 August 2017

3

Cezmi A Akdis

1 reference

12 August 2017

4

Mübeccel Akdis

1 reference

12 August 2017

Johan Verhagen

1

1 reference

ORCID Public Data File 2021

language of work or name

English

0 references

publication date

1 April 2005

1 reference

Expert Opinion on Biological Therapy

12 August 2017

published in

1 reference

12 August 2017

volume

5

1 reference

12 August 2017

issue

4

1 reference

12 August 2017

page(s)

537-544

1 reference

Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.537

T regulatory cells in allergy and health: a question of allergen specificity and balance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.537

Development of allergen-specific T-cell memory in atopic and normal children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.537

Characterization of T cell subpopulations involved in the pathogenesis of asthma and allergic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.537

T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.537

Immune regulation in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.537

T helper (Th) 2 predominance in atopic diseases is due to preferential apoptosis of circulating memory/effector Th1 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.537

Lymphokine production by human T cells in disease states

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.537

IL-13 in allergy: home at last

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.537

Peptide immunotherapy for allergic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.537

Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.537

Genetic immunization is a simple method for eliciting an immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.537

Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.537

The effect of vaccination with DNA encoding murine T-cell epitopes on the Der p 1 and 2 induced immunoglobulin E synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.537

Noninjection routes for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.537

Is sublingual immunotherapy clinically effective?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.537

Impact of sublingual immunotherapy on specific antibody levels in asthmatic children allergic to house dust mites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.537

Bacillus Calmette-Guérin-induced interleukin-12 did not additionally improve clinical and immunologic parameters in asthmatic children treated with sublingual immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.537

Inhibition of an established allergic response to ovalbumin in BALB/c mice by killed Mycobacterium vaccae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.537

Inhibition of T helper 2-type responses, IgE production and eosinophilia by synthetic lipopeptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.537

A novel approach to specific allergy treatment: the recombinant fusion protein of a bacterial cell surface (S-layer) protein and the major birch pollen allergen Bet v 1 (rSbsC-Bet v 1) combines reduced allergenicity with immunomodulating capacity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.537

Selective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to immunostimulatory DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.537

Immunotherapeutic uses of CpG oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.537

Role of interleukin 10 in specific immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.537

IL‐10 and TGF‐β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.537

Grass pollen immunotherapy: efficacy and safety during a 4-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.537

Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.537

Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.537

The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.537

Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.537

Low-affinity IgE receptor (CD23) function on mouse B cells: role in IgE-dependent antigen focusing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.537

Effect of transmembrane and cytoplasmic domains of IgE on the IgE response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.537

Three years of specific immunotherapy with house-dust-mite extracts in patients with rhinitis and asthma: significant improvement of allergen-specific parameters and of nonspecific bronchial hyperreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.537

Allergen-specific conventional immunotherapy decreases immunoglobulin E-mediated basophil histamine releasability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.537

Interleukin (IL)-10 inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.537

PROPHYLACTIC INOCULATION AGAINST HAY FEVER

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.537

Blockade of CTLA-4 enhances allergic sensitization and eosinophilic airway inflammation in genetically predisposed mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.537

Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.537

21 January 2018

Identifiers

DOI

10.1517/14712598.5.4.537

1 reference

12 August 2017

1 reference